UHMK1 is a novel marker for personalized prediction of pancreatic cancer prognosis

Pancreatic ductal adenocarcinoma (PDAC) is among the leading causes of cancer mortality, and new therapeutic options are urgently needed. Long noncoding RNA H19 (H19) is known to promote PDAC progression, but the downstream genes of H19 are largely unknown. Five PDAC cell lines, nonmalignant pancrea...

Full description

Saved in:
Bibliographic Details
Main Authors: Luo, Yiqiao (Author) , Han, Shanshan (Author) , Yan, Bin (Author) , Ji, Huihui (Author) , Zhao, Lian (Author) , Gladkich, Jury (Author) , Herr, Ingrid (Author)
Format: Article (Journal)
Language:English
Published: 10 March 2022
In: Frontiers in oncology
Year: 2022, Volume: 12, Pages: 1-15
ISSN:2234-943X
DOI:10.3389/fonc.2022.834647
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fonc.2022.834647
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/article/10.3389/fonc.2022.834647
Get full text
Author Notes:Yiqiao Luo, Shanshan Han, Bin Yan, Huihui Ji, Lian Zhao, Jury Gladkich and Ingrid Herr

MARC

LEADER 00000caa a2200000 c 4500
001 180118111X
003 DE-627
005 20251106121936.0
007 cr uuu---uuuuu
008 220509s2022 xx |||||o 00| ||eng c
024 7 |a 10.3389/fonc.2022.834647  |2 doi 
035 |a (DE-627)180118111X 
035 |a (DE-599)KXP180118111X 
035 |a (OCoLC)1341459736 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Luo, Yiqiao  |d 1990-  |e VerfasserIn  |0 (DE-588)1194586996  |0 (DE-627)1676809228  |4 aut 
245 1 0 |a UHMK1 is a novel marker for personalized prediction of pancreatic cancer prognosis  |c Yiqiao Luo, Shanshan Han, Bin Yan, Huihui Ji, Lian Zhao, Jury Gladkich and Ingrid Herr 
246 3 0 |a one 
264 1 |c 10 March 2022 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 31.05.2022 
520 |a Pancreatic ductal adenocarcinoma (PDAC) is among the leading causes of cancer mortality, and new therapeutic options are urgently needed. Long noncoding RNA H19 (H19) is known to promote PDAC progression, but the downstream genes of H19 are largely unknown. Five PDAC cell lines, nonmalignant pancreatic cells, TCGA, GEO-derived pancreatic tissues (malignant, n=413; nonmalignant, n=234), a pancreatic tissue array (n=96), and pancreatic tissues from our clinic (malignant, n=20; nonmalignant, n=20) were examined by a gene array, RT-qPCR, Western blotting, MTT, colony formation, wound-healing, siRNA-mediated gene silencing, bioinformatics, xenotransplantation, and immunohistochemistry assays. The cell cycle inhibitor, UHMK1, was identified to have the strongest correlation with H19. UHMK1 expression was enhanced in PDAC, and high UHMK1 expression correlated with tumor stage, and lower overall survival. siRNA-mediated UHMK1 downregulation inhibited progression signaling. siRNA-mediated downregulation of H19 or UHMK1 inhibited tumor proliferation and xenograft growth. Based on the correlation between UHMK1 expression and clinical parameters, we developed a nomogram that reliably predicts patient prognosis and overall survival. Together, we characterized UHMK1 as an H19-induced oncogene and verified it as a novel PDAC prognostic marker for overall survival. 
700 1 |a Han, Shanshan  |e VerfasserIn  |4 aut 
700 1 |a Yan, Bin  |e VerfasserIn  |0 (DE-588)1241137420  |0 (DE-627)1770443975  |4 aut 
700 1 |a Ji, Huihui  |d 1989-  |e VerfasserIn  |0 (DE-588)1241137722  |0 (DE-627)1770444424  |4 aut 
700 1 |a Zhao, Lian  |d 1995-  |e VerfasserIn  |0 (DE-588)1378279832  |0 (DE-627)1937769526  |4 aut 
700 1 |a Gladkich, Jury  |e VerfasserIn  |0 (DE-588)1078800960  |0 (DE-627)839492529  |0 (DE-576)45190480X  |4 aut 
700 1 |a Herr, Ingrid  |e VerfasserIn  |0 (DE-588)114884242  |0 (DE-627)691233276  |0 (DE-576)168702436  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in oncology  |d Lausanne : Frontiers Media, 2011  |g 12(2022), Artikel-ID 834647, Seite 1-15  |h Online-Ressource  |w (DE-627)684965518  |w (DE-600)2649216-7  |w (DE-576)35841184X  |x 2234-943X  |7 nnas  |a UHMK1 is a novel marker for personalized prediction of pancreatic cancer prognosis 
773 1 8 |g volume:12  |g year:2022  |g elocationid:834647  |g pages:1-15  |g extent:15  |a UHMK1 is a novel marker for personalized prediction of pancreatic cancer prognosis 
856 4 0 |u https://doi.org/10.3389/fonc.2022.834647  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://www.frontiersin.org/article/10.3389/fonc.2022.834647  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20220509 
993 |a Article 
994 |a 2022 
998 |g 114884242  |a Herr, Ingrid  |m 114884242:Herr, Ingrid  |d 910000  |d 910200  |d 50000  |e 910000PH114884242  |e 910200PH114884242  |e 50000PH114884242  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 7  |y j 
998 |g 1378279832  |a Zhao, Lian  |m 1378279832:Zhao, Lian  |d 50000  |e 50000PZ1378279832  |k 0/50000/  |p 5 
998 |g 1241137722  |a Ji, Huihui  |m 1241137722:Ji, Huihui  |d 50000  |e 50000PJ1241137722  |k 0/50000/  |p 4 
998 |g 1241137420  |a Yan, Bin  |m 1241137420:Yan, Bin  |d 50000  |e 50000PY1241137420  |k 0/50000/  |p 3 
999 |a KXP-PPN180118111X  |e 4130268511 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 31.05.2022"],"language":["eng"],"recId":"180118111X","person":[{"family":"Luo","given":"Yiqiao","display":"Luo, Yiqiao","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Han, Shanshan","given":"Shanshan","family":"Han"},{"family":"Yan","given":"Bin","display":"Yan, Bin","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Huihui","family":"Ji","role":"aut","display":"Ji, Huihui","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Zhao, Lian","given":"Lian","family":"Zhao"},{"role":"aut","display":"Gladkich, Jury","roleDisplay":"VerfasserIn","given":"Jury","family":"Gladkich"},{"role":"aut","display":"Herr, Ingrid","roleDisplay":"VerfasserIn","given":"Ingrid","family":"Herr"}],"title":[{"title":"UHMK1 is a novel marker for personalized prediction of pancreatic cancer prognosis","title_sort":"UHMK1 is a novel marker for personalized prediction of pancreatic cancer prognosis"}],"physDesc":[{"extent":"15 S."}],"relHost":[{"note":["Gesehen am 07.11.13"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"UHMK1 is a novel marker for personalized prediction of pancreatic cancer prognosisFrontiers in oncology","recId":"684965518","language":["eng"],"pubHistory":["2011 -"],"part":{"year":"2022","pages":"1-15","volume":"12","text":"12(2022), Artikel-ID 834647, Seite 1-15","extent":"15"},"title":[{"title":"Frontiers in oncology","title_sort":"Frontiers in oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Lausanne","publisher":"Frontiers Media","dateIssuedKey":"2011","dateIssuedDisp":"2011-"}],"id":{"eki":["684965518"],"zdb":["2649216-7"],"issn":["2234-943X"]}}],"name":{"displayForm":["Yiqiao Luo, Shanshan Han, Bin Yan, Huihui Ji, Lian Zhao, Jury Gladkich and Ingrid Herr"]},"origin":[{"dateIssuedDisp":"10 March 2022","dateIssuedKey":"2022"}],"id":{"eki":["180118111X"],"doi":["10.3389/fonc.2022.834647"]}} 
SRT |a LUOYIQIAOHUHMK1ISANO1020